HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Down syndrome maternal serum marker screening after 18 weeks of gestation: a countrywide study.

AbstractOBJECTIVE:
The objective of the study was to evaluate the efficacy of maternal serum markers in detecting Down syndrome after 18 weeks of gestation in women who book late for maternity care in a large national retrospective study.
STUDY DESIGN:
During the period 2007-2012, 27,648 women, regardless of maternal age (17.4% were 35 years old and over), were included in a late Down syndrome screening program (18(+0) to 35(+6) weeks) using the maternal serum markers alpha-fetoprotein and human chorionic gonadotrophin-beta. Samples were assayed in a single laboratory. A dataset of median markers previously established in our laboratory was used for risk calculation. The control group consisted of 27,648 women (14(+0) to 17(+6) weeks) randomly selected from the routine database.
RESULTS:
When the later screening group was compared with the standard second-trimester control group, the median multiples of medians (1.01 vs 0.98 for alpha-fetoprotein, 1.03 vs 0.98 for human chorionic gonadotrophin-beta), median risks (1 of 2414 vs 1 of 2720), false-positive rates (11.1% vs 11.6%), and trisomy 21 detection rates (83.3% vs 85.7%) did not differ significantly.
CONCLUSION:
Late Down syndrome maternal serum screening is feasible with a good sensitivity/specificity compromise throughout gestation and is of clinical value in late-booking women.
AuthorsSophie Dreux, Claire Nguyen, Isabelle Czerkiewicz, Thomas Schmitz, Elie Azria, Marc-Antoine Fouré, Françoise Muller, ABA Study Group
JournalAmerican journal of obstetrics and gynecology (Am J Obstet Gynecol) Vol. 208 Issue 5 Pg. 397.e1-5 (May 2013) ISSN: 1097-6868 [Electronic] United States
PMID23353023 (Publication Type: Evaluation Study, Journal Article)
CopyrightCopyright © 2013 Mosby, Inc. All rights reserved.
Chemical References
  • AFP protein, human
  • Biomarkers
  • Chorionic Gonadotropin, beta Subunit, Human
  • alpha-Fetoproteins
Topics
  • Adult
  • Biomarkers (blood)
  • Case-Control Studies
  • Chorionic Gonadotropin, beta Subunit, Human (blood)
  • Down Syndrome (diagnosis)
  • False Positive Reactions
  • Female
  • France
  • Humans
  • Mass Screening (methods)
  • Maternal Serum Screening Tests
  • Middle Aged
  • Pregnancy
  • Pregnancy Trimester, Second (blood)
  • Prenatal Care (methods)
  • Retrospective Studies
  • Sensitivity and Specificity
  • alpha-Fetoproteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: